Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,993
Total Claims
$1.7M
Drug Cost
502
Beneficiaries
$3,371
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-41%
Opioid rate vs peers
1.5% vs 2.5% avg
+199%
Cost per patient vs peers
$3,371 vs $1,128 avg
+124%
Brand preference vs peers
18.8% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.5%
Opioid Rate
292
Opioid Claims
$9,327
Opioid Cost
12.0%
Long-Acting Rate
Brand vs Generic
Brand: 3,735 claims · $1.2M
Generic: 16,119 claims · $526K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 642 | $188K |
| Dulaglutide | 175 | $112K |
| Bictegrav/Emtricit/Tenofov Ala | 21 | $84K |
| Rifaximin | 24 | $50K |
| Glatiramer Acetate | 15 | $49K |
| Sitagliptin Phosphate | 142 | $47K |
| Rivaroxaban | 176 | $44K |
| Insulin Aspart | 143 | $40K |
| Mirabegron | 122 | $33K |
| Paliperidone Palmitate | 13 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 126 | $25K |
| Budesonide/Formoterol Fumarate | 51 | $21K |
| Insulin Detemir | 72 | $20K |
| Insulin Detemir | 59 | $19K |
| Divalproex Sodium | 240 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
59%
Female
3.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About